Drug intelligence / Profile preview

Feedcolon + mesalamine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Rectal (for Some Formulations Of Mesalamine)[1][2][7]
01

Overview

Feedcolon + mesalamine is a combination drug product containing two active ingredients. Mesalamine (also known as 5-aminosalicylic acid or 5-ASA) is an anti-inflammatory agent used primarily to treat and prevent flare-ups of mild to moderately active ulcerative colitis, an inflammatory bowel disease affecting the colon. It works by exerting a topical anti-inflammatory effect on the colonic epithelial cells, likely through inhibition of cyclooxygenase and lipoxygenase pathways, thereby reducing prostaglandin and leukotriene production in the colon. The specific identity and pharmacological role of "Feedcolon" are not established in major medical databases or literature; it may be a regional brand name or proprietary formulation combined with mesalamine for gastrointestinal use. Without further information about "Feedcolon," only the properties of mesalamine can be described with certainty.

Brand names
Feedcolon + mesalamine
02

Targets

Beyond the preview

Go deeper on Feedcolon + mesalamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Feedcolon + mesalamine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call